TWST
Twist Bioscience Corporation
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$124.72
−3.10%Margins
Gross margin
52.0%
EBITDA margin
-25.0%
EBIT margin
-31.9%
Net margin
-31.7%
FCF margin
-21.6%
-30.7%
Return on equity
-20.3%
Return on assets
-25.5%
Return on invested capital
0.64x
Asset turnover
-$53.1M
Cash from operations
$2.53
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026